Literature DB >> 6201225

Effect of electroconvulsive therapy on serum myelin basic protein immunoreactivity.

N R Hoyle, R T Pratt, D G Thomas.   

Abstract

A sensitive radioimmunoassay that can detect brain damage in cases of head injury and stroke was applied to blood samples from 13 patients before and after they received multiple treatments with electroconvulsive therapy for psychiatric disorder. None of the patients showed a significant increase in serum myelin basic protein immunoreactivity. As increased serum myelin basic protein immunoreactivity may reflect myelin damage it is apparent that in these patients electroconvulsive therapy did not cause measureable breakdown of myelin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6201225      PMCID: PMC1441407          DOI: 10.1136/bmj.288.6424.1110

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  5 in total

1.  Myelin basic protein in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases.

Authors:  A Biber; D Englert; D Dommasch; K Hempel
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

Review 2.  The present status of electroconvulsive therapy.

Authors:  R E Kendell
Journal:  Br J Psychiatry       Date:  1981-10       Impact factor: 9.319

3.  Acute hypertension causing blood-brain barrier breakdown during epileptic seizures.

Authors:  T G Bolwig; M M Hertz; E Westergaard
Journal:  Acta Neurol Scand       Date:  1977-10       Impact factor: 3.209

4.  The permeability of the blood-brain barrier during electrically induced seizures in man.

Authors:  T G Bolwig; M M Hertz; O B Paulson; H Spotoft; O J Rafaelsen
Journal:  Eur J Clin Invest       Date:  1977-04       Impact factor: 4.686

5.  Radioimmunoassay of human myelin basic protein in tissue extract, cerebrospinal fluid and serum and its clinical application to patients with head injury.

Authors:  J W Palfreyman; D G Thomas; J G Ratcliffe
Journal:  Clin Chim Acta       Date:  1978-01-16       Impact factor: 3.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.